Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Sell
2,564
-36,676
-93% -$7.89M 0.04% 139
2026
Q1
$8.42M Hold
39,240
0.55% 76
2025
Q4
$8.97M Sell
39,240
-1,015
-3% -$231K 0.53% 64
2025
Q3
$8.5M Buy
40,255
+35,298
+712% +$7.19M 0.59% 55
2025
Q2
$840K Hold
4,957
0.06% 128
2025
Q1
$1.01M Hold
4,957
0.08% 122
2024
Q4
$881K Hold
4,957
0.06% 132
2024
Q3
$977K Buy
+4,957
New +$925K 0.07% 130

Other funds holding ABBV

Sienna Gestion's ABBV Position: Q2 2026 in Review

Sienna Gestion reduced its AbbVie (ABBV) stake by 93% in Q2 2026, selling an estimated $7.89M and leaving 2,564 shares worth $659K. The position accounts for 0.04% of the portfolio, ranked #139.

Sienna Gestion first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.97M in Q4 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sienna Gestion held 2,564 shares of AbbVie worth $659K as of Q2 2026.
  • Sienna Gestion sold 36,676 AbbVie shares in Q2 2026, an estimated $7.89M.
  • AbbVie made up 0.04% of Sienna Gestion's portfolio in Q2 2026, its #139 holding.
  • Sienna Gestion first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • Sienna Gestion's AbbVie position peaked at $8.97M in Q4 2025.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sienna Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.